Novozymes A/S (NZYMb.CO)
Latest Key Developments (Source: Significant Developments)
Coor Service Management Holding AB
Novozymes A/S:Outlook for FY 2016 organic sales growth and for net profit growth is unchanged.The outlook for sales and EBIT growth in Danish crowns is adjusted from 3-5 percent to 1-3 percent to account for the lower currency exchange rates. Full Article
Novozymes A/S:Changes in organizational structure and executive leadership team.Says wishes to strengthen its technology and market leadership through establishment of a central research, innovation & supply organization.Says the costs are expected to be realized Q1 2016 and within the financial outlook provided on Jan. 19, 2016; hence FY 2016 outlook remains unchanged.Says announces formation of three divisions: Household Care & Technical Industries, Agriculture & Bioenergy and Food & Beverages.Says expects that total costs associated with the reorganization will be 60-70 million Danish crowns. Full Article
Novozymes A/S:Says it and Adisseo 600299.SS have launched their first probiotic for poultry on the U.S. market and in a number of countries in the Middle East and South East Asia.Says the product optimizes feed conversion by 2 to 2.5 percent, meaning less feed consumed to raise an animal.Says estimates the probiotics market at 200-300 million euros ($217-325 million) and 8-10 percent annual growth.The partners strive to become key players in probiotics for animals and accelerate the expansion of the market. Full Article
COPENHAGEN, April 12 Danish life science investor Novo A/S said on Wednesday it was raising its stake in Synlab to about 20 percent through a 250 million euro ($265 million) subscription to new shares, ahead of a potential listing of Europe's second largest lab operator.